Blue Summit Biochemical: Hainan Wenqin plans to reduce its holdings in the company by no more than 2.61% of the shares.

On the evening of July 29th, Lanfeng Biochemical announced that shareholder Hainan Wenqin Private Equity Fund Management Partnership Enterprise - Wenqin Shun, which holds 8.95% of the company's shares, will reduce its holdings of the company's shares by no more than 9.7956 million shares through centralized bidding and block trading of the 1st private equity securities investment fund, accounting for no more than 2.61% of the total share capital of the company.